Abstract
The diagnosis of Parkinson disease (PD) and dementia with Lewy bodies (DLB) is often not straightforward. When PD symptoms are atypical or overlap with other diseases (eg, essential tremor [ET] or drug induced), [123I] N-ω-fluoropropyl-2β-carbomethoxy-3b-(4-iodophenyl) nortropane ([ 123I]FP-CIT) single-photon emission computed tomography (SPECT) can improve the diagnostic accuracy. The potential side effects of medications for PD may be avoided, if [123I]FP-CIT SPECT is normal. [ 123I]FP-CIT SPECT is helpful in the diagnosis of DLB, differentiating it from other causes of dementia such as Alzheimer disease (AD).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 459-467 |
| Number of pages | 9 |
| Journal | PET Clinics |
| Volume | 8 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2013 |
Keywords
- Dementia
- Dopamine
- Parkinson disease
- SPECT
ASJC Scopus subject areas
- Radiation
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'Dopamine transporter SPECT imaging in parkinson disease and dementia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS